Del Vecchio S, Reynolds J C, Blasberg R G, Neumann R D, Carrasquillo J A, Hellström I, Larson S M
Nuclear Medicine Department, NIH, Bethesda, Maryland 20892.
Cancer Res. 1988 Oct 1;48(19):5475-81.
An assay method that uses 125I-labeled monoclonal antibody (MoAb) and in vitro quantitative autoradiography was developed to determine the local concentration of tumor-associated antigens in tissue sections. Human melanoma biopsy specimens were evaluated for the expression of the Mr 97,000 and 250,000 protein antigens using MoAb-96.5 and MoAb-9.2.27, respectively. Tissue sections were incubated in solutions of increasing concentration of 125I-labeled MoAb with or without an excess of unlabeled antibody. Quantitative autoradiography was performed on the sections and compared with 125I standards to determine tumor-bound radioactivity and calculate bound pmol of MoAb per g of tumor. The total binding, nonsaturable binding, and specific binding of 125I-labeled MoAb to tumor were then computed. Specific binding of MoAbs to tumor tissue was saturable in all antigen-positive tumors. The maximal concentration of specific binding of antibody to tissue (Bmax) represented the tissue antigen concentration. Estimates of the Ka of antigen/antibody binding were also made. The reliability of the measurements was confirmed by testing sections from mixtures of antigen-positive and antigen-negative cells.
开发了一种使用¹²⁵I标记单克隆抗体(MoAb)和体外定量放射自显影术的测定方法,以确定组织切片中肿瘤相关抗原的局部浓度。分别使用MoAb - 96.5和MoAb - 9.2.27评估人黑色素瘤活检标本中97,000和250,000 Mr蛋白抗原的表达。将组织切片在含有或不含有过量未标记抗体的¹²⁵I标记MoAb浓度递增的溶液中孵育。对切片进行定量放射自显影,并与¹²⁵I标准品进行比较,以确定肿瘤结合的放射性,并计算每克肿瘤中结合的MoAb的皮摩尔数。然后计算¹²⁵I标记的MoAb与肿瘤的总结合、非饱和结合和特异性结合。在所有抗原阳性肿瘤中,MoAb与肿瘤组织的特异性结合是可饱和的。抗体与组织特异性结合的最大浓度(Bmax)代表组织抗原浓度。还对抗原/抗体结合的Ka进行了估计。通过测试抗原阳性和抗原阴性细胞混合物的切片,证实了测量的可靠性。